EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 343 filers reported holding EXELIXIS INC in Q3 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $202,000 | -29.1% | 11,070 | -17.9% | 0.00% | -33.3% |
Q3 2021 | $285,000 | -4.7% | 13,480 | -17.9% | 0.00% | 0.0% |
Q2 2021 | $299,000 | -22.1% | 16,415 | -3.5% | 0.00% | -25.0% |
Q1 2021 | $384,000 | -39.1% | 17,003 | -45.9% | 0.00% | -42.9% |
Q4 2020 | $631,000 | -25.0% | 31,446 | -8.5% | 0.01% | -41.7% |
Q3 2020 | $841,000 | +36.3% | 34,385 | +32.4% | 0.01% | +50.0% |
Q2 2020 | $617,000 | +77.8% | 25,975 | +60.1% | 0.01% | +166.7% |
Q2 2019 | $347,000 | -14.7% | 16,225 | -5.0% | 0.00% | 0.0% |
Q1 2019 | $407,000 | -34.5% | 17,081 | -45.9% | 0.00% | -40.0% |
Q4 2018 | $621,000 | +21.3% | 31,561 | +9.3% | 0.01% | +66.7% |
Q3 2018 | $512,000 | +28.6% | 28,870 | +55.9% | 0.00% | 0.0% |
Q2 2018 | $398,000 | -46.6% | 18,515 | -45.0% | 0.00% | -50.0% |
Q1 2018 | $746,000 | +17.5% | 33,688 | +61.2% | 0.01% | +50.0% |
Q4 2017 | $635,000 | -89.8% | 20,903 | -91.9% | 0.00% | -90.9% |
Q3 2017 | $6,239,000 | +1.7% | 257,504 | +3.4% | 0.04% | +2.3% |
Q2 2017 | $6,136,000 | +33.7% | 249,144 | +17.6% | 0.04% | +34.4% |
Q1 2017 | $4,590,000 | +12.3% | 211,793 | -22.7% | 0.03% | +6.7% |
Q4 2016 | $4,087,000 | +8.8% | 274,106 | -6.6% | 0.03% | -3.2% |
Q3 2016 | $3,756,000 | +49.6% | 293,629 | -8.6% | 0.03% | +40.9% |
Q2 2016 | $2,510,000 | – | 321,335 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |